Davita Inc. v. Virginia Mason Memorial

981 F.3d 679
Court of Appeals for the Ninth Circuit·Decided November 24, 2020·No. 19-35692·Published·Cited by 3 cases

Opinion

FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS NOV 24 2020 MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

DAVITA INC., No. 19-35692 Plaintiff-Appellant, D.C. No. 2:19-cv-00302-BJR

v.

OPINION

VIRGINIA MASON MEMORIAL HOSPITAL, FKA Yakima Valley Memorial Hospital; YAKIMA VALLEY MEMORIAL HOSPITAL EMPLOYEE HEALTH CARE PLAN,

Defendants-Appellees.

Appeal from the United States District Court for the Western District of Washington Barbara Jacobs Rothstein, District Judge, Presiding

Argued and Submitted October 8, 2020 Seattle, Washington

Before: Susan P. Graber and William A. Fletcher, Circuit Judges, and Leslie E. Kobayashi,* District Judge.

Opinion by Judge Graber

GRABER, Circuit Judge:

*

The Honorable Leslie E. Kobayashi, United States District Judge for the District of Hawaii, sitting by designation.

Defendant Virginia Mason Memorial Hospital administers its own group health plan, Defendant Yakima Valley Memorial Hospital’s Employee Health Care Plan ("Virginia Mason's Plan" or "the Plan"). Among its many provisions, the Plan authorizes payments to providers of dialysis, a critical treatment for persons with end-stage renal disease ("ESRD"). Persons with ESRD become eligible for Medicare after three months of dialysis treatment, even if not otherwise eligible for Medicare. When, as here, both Medicare and another insurer have independent obligations to pay for a service such as dialysis, Congress—in the Medicare as Secondary Payer provisions ("MSP"), 42 U.S.C. § 1395y(b)—has decreed who pays first and who pays second. The MSP also imposes substantive requirements on group health plans, including by forbidding plans from taking into account an ESRD patient’s eligibility for Medicare during the first thirty months of Medicare eligibility. Id. § 1395y(b)(1)(C).

Plaintiff DaVita, Inc., brought this action pursuant to the MSP’s private cause of action, id. § 1395y(b)(3)(A), which authorizes suit when a plan fails to make a statutorily compliant primary payment. DaVita provides dialysis treatment to patients, including a beneficiary of Virginia Mason’s Plan known as "Patient 1." DaVita alleges that Defendants reduced the payment amount for Patient 1’s dialysis because of Medicare eligibility as soon as Patient 1 became eligible for Medicare, without waiting the mandatory thirty months. But the reduced payment

amount remained greater than the Medicare rate, so Medicare never made any secondary payments. The district court dismissed the complaint, holding that the MSP’s private cause of action is available only when Medicare has made a payment.

Reviewing de novo and taking the allegations in the complaint as true, Daewoo Elecs. Am., Inc. v. Opta Corp., 875 F.3d 1241, 1246 (9th Cir. 2017), we hold that dismissal of the complaint on that ground was erroneous. The statutory text, congressional purpose, and regulatory clues make clear that Congress did not intend payment by Medicare to be a prerequisite to bringing a private cause of action under the MSP. The private cause of action encompasses situations in which a primary plan impermissibly takes Medicare eligibility into account too soon, even if Medicare has not made any payments. Accordingly, we vacate in large part and remand for further proceedings.

BACKGROUND

A. ESRD and Medicare More than 700,000 people in the United States have ESRD, also known as kidney failure. To survive, a person with ESRD requires either a kidney transplant or routine maintenance dialysis. 42 C.F.R. § 406.13(b); see also Kidney Disease Statistics for the United States, Nat’l Insts. of Health (December 2016), https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease.

Dialysis acts as a substitute for a functioning kidney. The most common form of dialysis for persons with ESRD is hemodialysis. Id. As described by DaVita, during hemodialysis, "[a] dialysis machine removes blood from the body, filters it through an artificial kidney, and then returns the cleaned blood." "Traditional, in- center dialysis is administered to a patient three times a week for about four hours each session." Most persons with ESRD never receive a kidney transplant, so they receive regular dialysis for the remainder of their lives. Dialysis is expensive, costing tens of billions of dollars annually in the United States.

Congress responded to the critical need for dialysis and the high cost of treatment. When Congress created Medicare in 1965, the program encompassed only two categories of eligibility: age and disability. 42 U.S.C. § 426 (1965). But many persons with ESRD did not qualify for Medicare and could not afford dialysis on their own. In 1972, Congress expanded Medicare by making all persons diagnosed with ESRD eligible for Medicare, regardless of age or disability. 42 U.S.C. § 426-1. A person diagnosed with ESRD becomes eligible for Medicare three months after first beginning regular maintenance dialysis (or sometimes sooner if the person receives a kidney transplant). Id. § 426-1(b).

Medicare is not, of course, the sole provider of healthcare benefits. Many other sources—such as worker’s compensation programs, tort-liability insurers, and group health plans—also provide healthcare benefits. When a patient is

covered by more than one program, which program must pay first can be a significant question.

Congress has allocated primary-payer responsibility between Medicare and other insurers through the MSP. For the 30 months following an individual’s Medicare eligibility due to ESRD, a group health plan may not "take into account" the person’s eligibility for Medicare. Id. § 1395y(b)(1)(C)(i). Following that 30- month period (33 months after treatment began), a group health plan may begin "paying benefits secondary to" Medicare. Id. § 1395y(b)(1)(C). In sum, for a person with ESRD who is covered by a group health plan, the plan is the sole payer during the first 3 months of dialysis; the plan is the primary payer and Medicare is the secondary payer during the 30-month coordination period; and the plan may be the secondary payer thereafter.

B. Factual and Procedural History Virginia Mason operates a nonprofit hospital in Yakima, Washington. Many hospital employees are eligible to enroll in Virginia Mason’s Plan, which is an "employee benefit plan" within the meaning of the Employee Retirement Income Security Act of 1974 ("ERISA").

Virginia Mason’s Plan provides varying rates of reimbursement for benefits depending on whether the beneficiary visits an "in-network" provider or an "out- of-network" provider. The Plan has a separate provision pertaining to

reimbursement for dialysis. In many circumstances, the Plan pays for dialysis services the same way it pays for all other covered services: "at applicable network or negotiated fee at in-network and out-of-network benefit levels." But "[o]nce the member becomes, or is eligible to become, qualified for Medicare coverage for ESRD and Medicare becomes or is eligible to become the secondary payer for ESRD services, the Plan will pay claims for ESRD services at 125% of the then current Medicare allowable [rate] for ESRD Services." DaVita alleges that, although the special reimbursement rate is higher than Medicare’s reimbursement rate, the special reimbursement rate is significantly lower than the ordinary rates paid to both in-network and out-of-network providers.

Free access — add to your briefcase to read the full text and ask questions with AI

Davita Inc. v. Virginia Mason Memorial, 981 F.3d 679 (9th Cir. 2020).

981 F.3d 679 (Davita Inc. v. Virginia Mason Memorial) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related